Aptar Pharma said that it has acquired US-based design firm Metaphase Design Group and will integrate the company into its subsidiary Noble, which Aptar acquired in 2019. Noble launched its Human Factors Plus (HF+) services for combination product development in 2021, and Aptar Pharma says that Metaphase’s capabilities will complement Noble’s offerings. Metaphase specializes in ergonomic design for a wide range of industries, including industrial machinery, food packaging, and consumer products as well as medical equipment.
Aptar Pharma President Gael Touya said, “We are pleased to welcome Metaphase to the Aptar Pharma family. The combined expertise of Noble and Metaphase in Human Factors fully aligns with our mission to bring the voice of the patient into all parts of the development process. At Aptar Pharma, our primary goal is improving patients’ experiences and health outcomes.”
Metaphase Design Group CEO Bryce Rutter commented, “We are excited to be joining Aptar Pharma and to expand our ability to impact the pharmaceutical industry and help our clients optimize the design of their devices, while continuing to serve our loyal client base in healthcare, consumer, and food and beverage markets. Combining our resources with the foundation that Noble has established with their Human Factors Plus program will also better enable us to represent the voice of the user throughout the product development journey.”
Read the Aptar press release.
